ロード中...
Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza
Background: Host-derived inflammatory responses contribute to the morbidity and mortality of severe influenza, suggesting that immunomodulatory therapy may improve outcomes. The normally circulating protein, human plasma gelsolin, is available in recombinant form (rhu-pGSN) and has beneficial effect...
保存先:
| 出版年: | F1000Res |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
F1000 Research Limited
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6894358/ https://ncbi.nlm.nih.gov/pubmed/31824672 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.21082.2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|